药学学报, 2019, 54(5): 877-885
庄莉, 翟园园, 姚卫峰, 徐佳, 冯丽, 包贝华, 曹雨诞, 张丽, 丁安伟. 基于网络药理学的二至丸对肾脏保护作用的机制研究[J]. 药学学报, 2019, 54(5): 877-885.
ZHUANG Li, ZHAI Yuan-yuan, YAO Wei-feng, XU Jia, FENG Li, BAO Bei-hua, CAO Yu-dan, ZHANG Li, DING An-wei. The mechanism study of protecting kidney of Erzhi Pill based on network pharmacology[J]. Acta Pharmaceutica Sinica, 2019, 54(5): 877-885.

庄莉1, 翟园园1,2, 姚卫峰1,2, 徐佳1,2, 冯丽1,2, 包贝华1,2, 曹雨诞1,2, 张丽1,2, 丁安伟1,2
1. 南京中医药大学药学院, 江苏 南京 210023;
2. 南京中医药大学江苏省方剂高技术研究重点实验室/江苏省中药资源产业化过程协同创新中心, 江苏 南京 210023
The mechanism study of protecting kidney of Erzhi Pill based on network pharmacology
ZHUANG Li1, ZHAI Yuan-yuan1,2, YAO Wei-feng1,2, XU Jia1,2, FENG Li1,2, BAO Bei-hua1,2, CAO Yu-dan1,2, ZHANG Li1,2, DING An-wei1,2
1. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China;
2. Jiangsu Key Laboratory for High Technology Research of TCM Formulae and Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China
Based on the concept of network pharmacology, the main nephroprotective components in Erzhi Pill reported in previous studies, were used to predict the targets through the PharmMapper method. Molecular docking was applied to screen for potential targets and biological information annotation databases (DAVID) was used to analyze the molecular function and biological process of the action targets. The Cytoscape software was used to construct the "ingredient-target-pathway" network of Erzhi Pill for renal injury treatment. TTD and GAD database were then applied to screen for the targets of renal disease for building "ingredient-core target" network. We found that 17 major active ingredients of Erzhi Pill regulated 32 targets (including ESR1, ESR2, GCK, MMP3) and affected 6 pathways, such as PI3K-Akt signaling pathway, estrogen signaling pathway and purine metabolism. This study reflected the nature of traditional Chinese medicine as multi-ingredients, multi-targets and multi-path ways, providing new clues for basic science research on the nephroprotective pharmacological mechanism of Erzhi Pill.
Key words:   
收稿日期: 2018-11-01
DOI: 10.16438/j.0513-4870.2018-0993
基金项目: 国家自然科学基金面上项目(81573554);江苏高校"青蓝工程"资助项目;江苏省"六大人才高峰"高层次人才项目(2016-YY026);江苏省高等学校大学生创新创业训练计划(201810315068Y);南京中医药大学大学生创新训练计划资助.
通讯作者: 姚卫峰,Tel:86-25-85811053,E-mail:yaowf@njucm.edu.cn
Email: yaowf@njucm.edu.cn
PDF(589KB) Free

[1] Li J, Lim SS, Lee JY, et al. Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation:possible renoprotective role in diabetic nephropathy[J]. J Nutr Biochem, 2012, 23:320-331.
[2] Stack AG, Casserly LF, Cronin CJ, et al. Prevalence and variation of chronic kidney disease in the irish health system:initial findings from the National Kidney Disease Surveillance Programme[J]. BMC Nephrol, 2014, 15:185.
[3] Hu DM, Chen XL, Lu Y, et al. Research progress on hepatopro tective effects of Erzhiwan and its components[J]. J Pharm Pract (药学实践杂志), 2016, 34:289-291.
[4] Lv DN. The application of erzhi pills in kidney diseases[J]. Jiangsu J Tradit Chin Med (江苏中医药), 2006, 27:54.
[5] Liu ZH, Sun XB. Network pharmacology:new opportunity for the modernization of traditional Chinese medicine[J]. Acta Pharm Sin (药学学报), 2012, 47:696-703.
[6] Liu X, Ouyang S, Yu B, et al. PharmMapper server:a web server for potential drug target identification using pharmacophore mapping approach[J]. Nucl Acids Res, 2010, 38:609-614.
[7] Zhai YY, Liu QN, Xu J, et al. Network pharmacology-based study on mechanism of liver protection of Erzhi Pill[J]. Acta Pharm Sin (药学学报), 2018, 53:567-573.
[8] Kitchen DB, Decornez H, Furr JR, et al. Docking and scoring in virtual screening for drug discovery:methods and applications[J]. Nat Rev Drug Discov, 2004, 3:935-949.
[9] Yang X, Li YH, Qian HB, et al. Molecular mechanism of ursolic acid against rheumatoid arthritis based on network pharma cology and molecular docking[J]. Chin J Exp Tradit Med Form (中国实验方剂学杂志), 2018, 24:207-214.
[10] Wang XJ, Lin ZJ, Zhang B, et al. Molecular docking analysis of xanthine oxidase inhibition by constituents of cichory[J]. China J Chin Mater Med (中国中药杂志), 2015, 40:3818-3825.
[11] Liu FH, Chen SJ, Ni WJ. Study on the computer virtual screening of antithrombotic active ingredients in Chuanxiong Rhizoma[J]. China Pharm (中国药房), 2017, 28:2182-2186.
[12] Wang ZY, Li CQ, Mu MJ, et al. Simultaneous determination of the content of danshensu, puerarin, daidzin and salvianolic acid B in Bushen Huoxue prescription by HPLC wavelength switching technology[J]. Chin J Pharm Anal (药物分析杂志), 2016, 36:1020-1026.
[13] Wu YL, Zhang HY. The protective effect of danshensu on renal injury in rats with SNP and its effect on NF-κB signaling pathway[J]. J Emerg Tradit Chin Med (中国中医急症), 2018, 27:1917-1921.
[14] Sun GX, Wu Y, Yang TT, et al. Dual referential fingerprint qualification method for dynamic technique criteria of Liuwei Dihuang Wan standard fingerprint by determination of 5 components and 6 wavelength fingerprints by high performance liquid chromatograpy[J]. Central South Pharm (中南药学), 2012, 10:385-392.
[15] Liu CM, Yang HX, Ma JQ, et al. Role of AMPK pathway in leadinduced endoplasmic reticulum stress in kidney and in paeonolinduced protection in mice[J]. Food Chem Toxicol, 2018, 122:1016-1024.
[16] Li H, Yao WF, Liu QN, et al. Application of UHPLC-ESI-QTOF-MS to identify multiple constituents in processed products of the herbal medicine Ligustri Lucidi Fructus[J]. Molecules, 2017, 22:689.
[17] Yao WF, Dai J, Zheng CZ, et al. Quality assessment of Fructus Ligustri Lucidi by the simultaneous determination of six com pounds and chemometric analysis[J]. J Sep Sci, 2015, 38:1822-1827.
[18] Nie Y, Yao WF. Study on the chemical components of Fructus Ligustri Lucidi[J]. J Nanjing Univ Tradit Chin Med (南京中医药大学学报), 2014, 30:475-477.
[19] Jiang YJ, Yao WF, Zhang L, et al. Analysis on chemical compo nents of Ligustrum lucidum by ultra performance liquid chroma tography-electrospray ionization-quadrupole-time of flight-mass spectrometry[J]. China J Chin Mater Med (中国中药杂志), 2012, 37:2304-2308.
[20] Anitha P, Anbarasu A, Ramaiah S. Gene network analysis reveals the association of important functional partners involved in anti biotic resistance:a report on an important pathogenic bacterium Staphylococcus aureus[J]. Gene, 2016, 575:253-263.
[21] Li X, Song Y, Zhang P, et al. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway[J]. Tumour Biol, 2016, 37:7599-7613.
[22] Li DZ, Liu XM, Song CJ, et al. Research progress of PI3K/Akt signaling pathway and PTEN in diabetic nephropathy[J]. J Chengde Med Coll (承德医学院学报), 2018, 35:69-73.
[23] Álvarez-Cilleros D, Martín MÁ, Ramos S. Protective effects of (-)-epicatechin and the colonic metabolite 3,4-dihydroxyphenyl acetic acid against glucotoxicity-induced insulin signalling blockade and altered glucose uptake and production in renal tubular NRK-52E cells[J]. Food Chem Toxicol, 2018, 120:119-128.
[24] Kim H, Kim SR, Je J, et al. The proximal tubular α7 nicotinic acetylcholine receptor attenuates ischemic acute kidney injury through Akt/PKC signaling-mediated HO-1 induction[J]. Exp Mol Med, 2018, 50:40.
[25] Chen N. Effect of the way to invigorate the circulation of blood on patients with hyperprolactinemia due to kidney deficiency and blood stasis[J]. Guangming J Chin Med (光明中医), 2017, 32:3587-3589.
[26] Dorenkamp M, Müller JP, Shanmuganathan KS, et al. Hypergly caemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2/SRC kinase signalling axis[J]. Sci Rep, 2018, 8:1-13.
[27] Cai JY, Li JH, Ding SH, et al. Progress in study of selective ERβ ligands[J]. Acta Pharm Sin (药学学报), 2015, 50:658-667.
[28] Zhang Y, Ji W, Zhou AF, et al. Estrogen regulates Th17/Treg cell immune balance to inhibit renal ischemia reperfusion injury[J]. Chin J Immun (中国免疫学杂志), 2018, 34:1601-1606.
[29] Lan LL, Jiang B, Liu MC, et al. Comparison of the establish ment of rat model of gouty nephropathy induced by yeast and adenine[J]. Chin J Comp Med (中国比较医学杂志), 2017, 27:33-43.
[30] Li S, Wang YY, Liu LR, et al. Role of focal adhesion kinase expression in renal tissues of type 2 diabetic rats[J]. Chin J Pathophys (中国病理生理杂志), 2013, 29:1400-1405.
[31] Anthony EG, Richard E, Lipkowitz MS, et al. Association of phosphodiesterase 4 polymorphism (rs702553) with blood pressure in the African American Study of Kidney Disease and Hypertension Genomics Study[J]. Pharmacogenet Genomics, 2013, 23:442-444.
[32] Jiang F, Yao N, Qian ZH, et al. The effect of eight compounds from Ligusrtum Lucidum Ait. on the glucose consumption of insulin resistance HepG2 cells[J]. Strait Pharm J (海峡药学), 2010, 22:164-167.
[33] Tong CC, Liu YE, Jin HX, et al. Protective mechanism of salidroside in the acute lung injury induced by LPS[J]. J Clin Emerg (临床急诊杂志), 2015, 16:667-671.
[34] Korotkov A, Broekaart DWM, van Scheppingen J, et al. Increased expression of matrix metalloproteinase 3 can be attenuated by inhibition of microRNA-155 in cultured human astrocytes[J]. J Neuroinflammation, 2018, 15:211.
[35] Nomani H, Hagh-Nazari L, Aidy A, et al. Association between GSTM1, GSTT1, and GSTP1 variants and the risk of end stage renal disease[J]. Ren Fail, 2016, 38:1455-1461.
[36] Zhu AN, Yang XX, Sun MY, et al. Associations between INSR and mTOR polymorphisms in type 2 diabetes mellitus and diabetic nephropathy in a Northeast Chinese Han population[J]. Genet Mol Res, 2015, 14:1808-1818.
[37] Tong F, Liu S, Yan B, et al. Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium[J]. Int J Nanomedicine, 2017, 12:7799-7813.
[38] Katyal T, Garg A, Budhiraja RD. Combination of daidzein, hemin and bms182874 halts the progression of diabetes-induced experi mental nephropathy[J]. Endocr Metab Immune, 2013, 13:152-162.
[39] Migliori M, Cantaluppi V, Mannari C, et al. Caffeic acid, a phenol found in white wine, modulates endothelial nitric oxide production and protects from oxidative stress-associated endo thelial cell injury[J]. PLoS One, 2015, 10:e0117530.
[40] Li CZ, Jin HH, Sun HX, et al. Eriodictyol attenuates cisplatininduced kidney injury by inhibiting oxidative stress and inflam mation[J]. Eur J Pharmacol, 2016, 772:124-130.
[41] Bao L, Li J, Zha D, et al. Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-κB pathways[J]. Int Immunopharmacol, 2018, 54:245-253.